[HTML][HTML] Advances in toxicology and medical treatment of chemical warfare nerve agents

M Moshiri, E Darchini-Maragheh… - DARU Journal of …, 2012 - Springer
Abstract Organophosphorous (OP) Nerve agents (NAs) are known as the deadliest chemical
warfare agents. They are divided into two classes of G and V agents. Most of them are liquid …

Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy

M de Araujo Furtado, F Rossetti, S Chanda, D Yourick - Neurotoxicology, 2012 - Elsevier
Epilepsy is a common neurological disorder characterized by an initial injury due to stroke,
traumatic brain injury, brain infection, or febrile seizures causing status epilepticus (SE). This …

Imidazole aldoximes effective in assisting butyrylcholinesterase catalysis of organophosphate detoxification

RK Sit, VV Fokin, G Amitai, KB Sharpless… - Journal of medicinal …, 2014 - ACS Publications
Intoxication by organophosphate (OP) nerve agents and pesticides should be addressed by
efficient, quickly deployable countermeasures such as antidotes reactivating …

[HTML][HTML] Recent developments on oximes to improve the blood brain barrier penetration for the treatment of organophosphorus poisoning: a review

MNF Norrrahim, MAIA Razak, NAA Shah, H Kasim… - RSC …, 2020 - pubs.rsc.org
Organophosphorus (OP) compounds are highly toxic synthetic compounds which have been
used as pesticides and developed as warfare nerve agents. They represent a threat to both …

Structure-activity relationship and efficacy of pyridinium oximes in the treatment of poisoning with organophosphorus compounds: a review of recent data

M Jokanovic - Current Topics in Medicinal Chemistry, 2012 - ingentaconnect.com
During more than five decades, pyridinium oximes have been developed as therapeutic
agents used in the medical treatment of poisoning with organophosphorus compounds …

Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro

F Worek, T Seeger, M Goldsmith, Y Ashani… - Archives of …, 2014 - Springer
The potent human toxicity of organophosphorus (OP) nerve agents calls for the development
of effective antidotes. Standard treatment for nerve agent poisoning with atropine and an …

Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study

F Worek, T Seeger, G Reiter, M Goldsmith, Y Ashani… - Toxicology Letters, 2014 - Elsevier
The highly toxic organophosphorus (OP) nerve agent VX is characterized by a remarkable
biological persistence which limits the effectiveness of standard treatment with atropine and …

[图书][B] Retrometabolic drug design and targeting

N Bodor, P Buchwald - 2012 - books.google.com
Innovative approach to drug design that's more likely to result in an approvable drug product
Retrometabolic drug design incorporates two distinct drug design approaches to obtain soft …

Catalytic detoxification of organophosphorus nerve agents by butyrylcholinesterase-polymer-oxime bioscavengers

L Zhang, H Murata, G Amitai, PN Smith… - …, 2020 - ACS Publications
Organophosphorus nerve agents (OPNAs), used in chemical warfare, irreversibly inhibit
essential cholinesterases (ChEs) in the cholinergic neurotransmission system. Several …

Oxime-mediated reactivation of organophosphate-inhibited acetylcholinesterase with emphasis on centrally-active oximes

JE Chambers, MB Dail, EC Meek - Neuropharmacology, 2020 - Elsevier
This review provides an overview of the global research leading to the large number of
compounds developed as reactivators of acetylcholinesterase inhibited by a variety of …